Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Balchem
(NASDAQ:BCPC)
Intraday
$139.26
0.76
[0.55%]
After-Hours
$139.26
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$139.26
0.76
[0.55%]
At close: Apr 26
$139.26
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 7 days from now on Fri May 3rd, before the market open
Conference call scheduled in 7 days at 11:00 AM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Balchem Stock (NASDAQ:BCPC)
Balchem Stock (NASDAQ: BCPC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 16, 2024
Balchem Q4 Adj. EPS $0.95 Beats $0.93 Estimate, Sales $228.70M Miss $234.66M Estimate
Benzinga Newsdesk
-
Feb 16, 2024, 7:02AM
Earnings Scheduled For February 16, 2024
Benzinga Insights
-
Feb 16, 2024, 4:45AM
Thursday, February 15, 2024
Balchem Earnings Preview
Benzinga Insights
-
Feb 15, 2024, 10:00AM
Monday, October 30, 2023
AbbVie To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Monday
Lisa Levin
-
Oct 30, 2023, 7:49AM
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $135
Benzinga Newsdesk
-
Oct 30, 2023, 6:53AM
Friday, October 27, 2023
Balchem shares are trading lower after the company reported mixed Q3 financial results.
Benzinga Newsdesk
-
Oct 27, 2023, 1:10PM
Balchem Q3 Adjusted EPS $1.04 Beats $0.97 Estimate, Sales $229.95M Miss $237.08M Estimate
Benzinga Newsdesk
-
Oct 27, 2023, 7:05AM
Earnings Scheduled For October 27, 2023
Benzinga Insights
-
Oct 27, 2023, 4:33AM
Thursday, October 26, 2023
Earnings Outlook For Balchem
Benzinga Insights
-
Oct 26, 2023, 12:01PM
Monday, July 31, 2023
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $165
Benzinga Newsdesk
-
Jul 31, 2023, 6:13AM
Friday, July 28, 2023
Balchem Q2 Adj EPS $1.06 Beats $0.84 Estimate, Sales $231.30M Miss $244.87M Estimate
Benzinga Newsdesk
-
Jul 28, 2023, 7:01AM
Earnings Scheduled For July 28, 2023
Benzinga Insights
-
Jul 28, 2023, 6:09AM
Thursday, July 27, 2023
Balchem Earnings Preview
Benzinga Insights
-
Jul 27, 2023, 12:02PM
Monday, June 05, 2023
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $150
Benzinga Newsdesk
-
Jun 5, 2023, 6:08AM
Friday, June 02, 2023
Shares of chemical companies are trading higher amid overall market strength on renewed economic optimism following US Senate passage of a debt limit bill and strong US jobs data.
Benzinga Newsdesk
-
Jun 2, 2023, 1:04PM
Thursday, May 04, 2023
Looking Into Balchem's Return On Capital Employed
Benzinga Insights
-
May 4, 2023, 10:52AM
Friday, April 28, 2023
Earnings Scheduled For April 28, 2023
Benzinga Insights
-
Apr 28, 2023, 8:24AM
Balchem Q1 Adj EPS $0.94 Beats $0.70 Estimate, Sales $232.54M Beat $231.83M Estimate
Benzinga Newsdesk
-
Apr 28, 2023, 7:01AM
Thursday, April 27, 2023
Balchem Earnings Preview
Benzinga Insights
-
Apr 27, 2023, 11:02AM
Monday, February 27, 2023
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $140
Benzinga Newsdesk
-
Feb 27, 2023, 6:09AM
Friday, February 24, 2023
Balchem Q4 Adj EPS $0.94 Beats $0.83 Estimate, Sales $232.53M Miss $241.47M Estimate
Benzinga Newsdesk
-
Feb 24, 2023, 7:07AM
Earnings Scheduled For February 24, 2023
Benzinga Insights
-
Feb 24, 2023, 4:11AM
Thursday, February 23, 2023
Preview: Balchem's Earnings
Benzinga Insights
-
Feb 23, 2023, 9:01AM
Monday, November 28, 2022
Balchem's Return on Invested Capital Overview
Benzinga Insights
-
Nov 28, 2022, 9:47AM
Monday, November 07, 2022
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152
Benzinga Newsdesk
-
Nov 7, 2022, 6:40AM
Friday, November 04, 2022
Recap: Balchem Q3 Earnings
Benzinga Insights
-
Nov 4, 2022, 10:07AM
Balchem Q3 EPS $1.00 Beats $0.85 Estimate, Sales $244.27M Beat $239.62M Estimate
Benzinga Newsdesk
-
Nov 4, 2022, 7:01AM
Earnings Scheduled For November 4, 2022
Benzinga Insights
-
Nov 4, 2022, 4:53AM
Thursday, November 03, 2022
Earnings Outlook For Balchem
Benzinga Insights
-
Nov 3, 2022, 12:45PM
Tuesday, August 30, 2022
Balchem Corporation Acquires Bergstrom Nutrition, No Terms Disclosed
Michael Horton
-
Aug 30, 2022, 4:08PM
Monday, August 22, 2022
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $164
Benzinga Newsdesk
-
Aug 22, 2022, 6:18AM
Friday, July 29, 2022
Recap: Balchem Q2 Earnings
Benzinga Insights
-
Jul 29, 2022, 8:01AM
Balchem Q2 EPS $1.07 Beats $1.00 Estimate, Sales $236.69M Beat $225.49M Estimate
Bill Haddad
-
Jul 29, 2022, 7:17AM
Earnings Scheduled For July 29, 2022
Benzinga Insights
-
Jul 29, 2022, 5:31AM
Thursday, July 28, 2022
Balchem's Earnings: A Preview
Benzinga Insights
-
Jul 28, 2022, 12:19PM
Tuesday, June 14, 2022
CORRECTION; Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS For Enterprise Value Of ~$338M
Bill Haddad
-
Jun 14, 2022, 7:02AM
Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS For Enterprise Value Of ~$338M
Bill Haddad
-
Jun 14, 2022, 7:01AM
Friday, May 06, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
May 6, 2022, 12:06PM
Balchem's Return on Invested Capital Insights
Benzinga Insights
-
May 6, 2022, 10:00AM
Tuesday, May 03, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
May 3, 2022, 12:20PM
Monday, May 02, 2022
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152
Benzinga Newsdesk
-
May 2, 2022, 6:11AM
Friday, April 29, 2022
Recap: Balchem Q1 Earnings
Benzinga Insights
-
Apr 29, 2022, 7:49AM
Balchem Q1 Adj. EPS $1.03 Beats $0.82 Estimate, Sales $228.90M Beat $207.69M Estimate
Benzinga Newsdesk
-
Apr 29, 2022, 7:10AM
Earnings Scheduled For April 29, 2022
Benzinga Insights
-
Apr 29, 2022, 4:36AM
Thursday, April 28, 2022
Earnings Preview: Balchem
Benzinga Insights
-
Apr 28, 2022, 11:07AM
Tuesday, March 08, 2022
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $155
Benzinga Newsdesk
-
Mar 8, 2022, 6:20AM
Tuesday, February 22, 2022
Sidoti & Co. Upgrades Balchem to Buy, Announces $175 Price Target
Benzinga Newsdesk
-
Feb 22, 2022, 8:59AM
Friday, February 18, 2022
Balchem Records 18% Revenue Growth In Q4, Tops Consensus
Shivani Kumaresan
-
Feb 18, 2022, 10:58AM
Balchem: Q4 Earnings Insights
Benzinga Insights
-
Feb 18, 2022, 7:22AM
Balchem Q4 Adj. EPS $0.85, Inline, Sales $213.13M Beat $198.17M Estimate
Benzinga Newsdesk
-
Feb 18, 2022, 7:07AM
Show more